1. Home
  2. PLPC vs TBPH Comparison

PLPC vs TBPH Comparison

Compare PLPC & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Preformed Line Products Company

PLPC

Preformed Line Products Company

HOLD

Current Price

$239.20

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$19.99

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLPC
TBPH
Founded
1947
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PLPC
TBPH
Price
$239.20
$19.99
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$27.80
AVG Volume (30 Days)
93.3K
379.1K
Earning Date
03-12-2026
02-25-2026
Dividend Yield
0.35%
N/A
EPS Growth
13.62
N/A
EPS
7.55
0.58
Revenue
$663,346,000.00
$80,327,000.00
Revenue This Year
$16.31
$70.78
Revenue Next Year
$13.74
N/A
P/E Ratio
$31.40
$34.88
Revenue Growth
15.93
27.12
52 Week Low
$118.99
$7.90
52 Week High
$251.67
$21.03

Technical Indicators

Market Signals
Indicator
PLPC
TBPH
Relative Strength Index (RSI) 54.92 54.60
Support Level $235.89 $19.53
Resistance Level $251.67 $21.03
Average True Range (ATR) 10.10 0.82
MACD -0.01 0.01
Stochastic Oscillator 63.75 57.05

Price Performance

Historical Comparison
PLPC
TBPH

About PLPC Preformed Line Products Company

Preformed Line Products Co is a designer and manufacturer of products and systems for constructing and maintaining overhead and underground networks for energy, telecommunication, cable operators, data communication, and other industries. In addition, it provides solar hardware systems and mounting hardware for a variety of solar power applications. Its products consist of Energy Products, Communications Products, and Special Industries Products. The company's majority of the revenue is derived from the sale of products in The Americas with operations also in PLP-USA, Europe, the Middle East and Africa, and Asia-Pacific. The revenue gets driven by Energy products which comprise protecting transmission conductors, spacers, spacer-dampers, and Stockbridge dampers.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: